THERAPEUTIC MODALITY | n | % |
MONOTHERAPY | 119 | 59.2 |
Beta-blockers | 105 | 88.23 |
Carbonic anhydrase inhibitors | 2 | 1.68 |
Prostaglandin agonists | 12 | 10.08 |
BITHERAPY | 77 | 38.3 |
Beta-blockers + Carbonic anhydrase inhibitors | 49 | 63.63 |
Beta-blockers + Prostaglandin agonists | 26 | 33.76 |
TRITHERAPY | 5 | 2.5 |
Beta-blockers + Carbonic anhydrase inhibitors + Prostaglandin agonists | 5 | 100 |